capmatinib

Italy

Drugs containing this active substance

TABRECTA

It is used to treat adults with advanced or metastatic non-small cell lung cancer (NSCLC) caused by a specific MET gene mutation.

Form: tablets, film-coated

Active substance	Dosage
capmatinib	-